The Latest Breaking News from FDA

Federal health advisers have narrowly backed an experimental vaccine from Pfizer that could become the first shot to protect older adults against the respiratory illness known as RSV

WASHINGTON — Pfizer Inc.’s vaccine for respiratory syncytial virus received endorsement from a key panel of U.S. advisers for its safety in people 60 and older, a key endorsement for the drugmaker’s potential product.

To the junior-most justice goes a case arising out of the Supreme Court's original jurisdiction concerning the Abandoned Money Orders and Traveler's Checks Act.

Artificial zero-calorie sweeteners are commonly used in processed and keto-friendly foods.

An infection that's usually easy to treat with common antibiotic eyedrops "has become an infection that can be deadly and has pretty much no treatment except one IV antibiotic,” one expert said.

Experts are marveling at how U.S. disease detectives figured out how eyedrops were linked to dozens of infections

Growth stock Novo Nordisk is showing strength after FDA approval of breakthrough oral drug for type 2 diabetes. Shares are in a base.

The Lucira COVID-19 and Flu Home Test is a single-use test, which can be purchased without a prescription.

Action on 15 March likely to coincide with PCS strike, taking number of civil servants participating above 100,000

The FDA will decide whether to approve a neurological disease drug from Reata Pharmaceuticals this week, but RETA stock plummeted Monday.

Pfizer (PFE) reported record-breaking revenue and earnings for fiscal 2022. Furthermore, the combination of expected launches and additional pipeline products position the company for continued robust growth through the rest of this decade and beyond. Amid a volatile macro environment, investing in this high-value stock for the long term could…